11 – 16 of 16
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2022
-
Mark
Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs : Results from four Nordic countries
- Contribution to journal › Article
-
Mark
ASAS-EULAR recommendations for the management of axial spondyloarthritis : 2022 update
- Contribution to journal › Article
- 2021
-
Mark
Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care : Does the choice of biological therapy matter?
- Contribution to journal › Article
-
Mark
Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population : A nationwide Swedish cohort study
- Contribution to journal › Article
- 2020
-
Mark
Development of intracranial vasculitis in giant cell arteritis during tocilizumab treatment
- Contribution to journal › Article
- 2013
-
Mark
Addition of biological therapies to palliative chemotherapy prolongs survival in patients with peritoneal carcinomatosis of colorectal origin
- Contribution to journal › Article
- « previous
- 1
- 2
- next »
